Oncare Hawaii Inc-Pali Momi is a clinical research site located in ‘Aiea, Hawaii, United States 96701.
Crixeo Health Trust Score: 76/100 (FAIR). This profile has not yet been claimed by the site owner.
Oncare Hawaii Inc-Pali Momi has participated in 12 clinical trials with 2 currently active.
Therapeutic areas: brca1 Mutation Carrier, brca2 Mutation Carrier, Breast Cancer.
Sponsors: SWOG Cancer Research Network, National Cancer Institute (NCI), Eastern Cooperative Oncology Group.
Trust Score: 76/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Oncare Hawaii Inc-Pali Momi has a Crixeo Trust Score of 76/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Oncare Hawaii Inc-Pali Momi has 12 clinical trials on record, with 2 currently active. Their work covers brca1 Mutation Carrier, brca2 Mutation Carrier, Breast Cancer.
Yes — Oncare Hawaii Inc-Pali Momi holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.